CORCEPT THERAPEUTICS INC (CORT) Stock News
NASDAQ:CORT - Nasdaq - US2183521028 - Common Stock - Currency: USD
CORT Latest News, Press Relases and Analysis
Corcept Therapeutics Therapy Fails Primary Goal But Extends Patient Survival In Amyotrophic Lateral Sclerosis Study
Corcept's ALS drug dazucorilant improved survival despite missing the main goal; ovarian cancer drug combo met its target in Phase 3.
Should Invesco S&P SmallCap Quality ETF (XSHQ) Be on Your Investing Radar?
Style Box ETF report for XSHQ
Corcept Presents Results from Phase 2 Study of Dazucorilant in Patients with Amyotrophic Lateral Sclerosis (ALS) at ENCALS 2025 Annual Meeting
New Strong Sell Stocks for May 29th
CORT, AETUF and MITT have been added to the Zacks Rank #5 (Strong Sell) List on May 29, 2025.
Mentions: MITT
Corcept (CORT) Down 1.7% Since Last Earnings Report: Can It Rebound?
Corcept (CORT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mentions: UTHR
Why Corcept Therapeutics Incorporated (CORT) Crashed On Monday
We recently published a list of These 10 Stocks Already Sank in June. In this article, we are going to take a look at where Corcept Therapeutics Incorporated (NASDAQ:CORT) stands against other worst performers on Monday. Corcept Therapeutics dropped for a third consecutive day on Monday, shedding 7.58 percent to end at $71.68 apiece as investors […]
CSX Corporation (CSX): It’s Important To Know How The Firm Is Doing, Says Jim Cramer
We recently published a list of Jim Cramer Says “We Have No Idea What’s Really Going To Happen” and Discusses These 12 Stocks. In this article, we are going to take a look at where CSX Corporation (NASDAQ:CSX) stands against other stocks that Jim Cramer discusses. CSX Corporation (NASDAQ:CSX) is one of the largest railroad […]
Why Corcept Therapeutics (CORT) Is Among the Best Performing Healthcare Stocks to Buy Now
We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look at where Corcept Therapeutics Incorporated (NASDAQ:CORT) stands against other best performing healthcare stocks to buy now. Trump’s Healthcare Executive Order Brings a Win On April 15, CNBC reported that President Trump’s […]
Is Cisco Systems, Inc. (CSCO) the Best Dow Stock?
We recently published a list of The Best and Worst Dow Stocks. In this article, we are going to take a look at where Cisco Systems, Inc. (NASDAQ:CSCO) stands against other Dow stocks. The Dow Jones Industrial Average is a benchmark index of the top 30 companies in the US. It represents the strength of […]
Corcept Therapeutics price target lowered to $135 from $150 at Truist
Truist analyst Joon Lee lowered the firm’s price target on Corcept Therapeutics (CORT) to $135 from $150 and keeps a Buy rating on the shares. The company’s Q1 Korlym revenue of $157.2M was softer than expected due to bandwidth issues with the pharmacy vendor, the analyst tells investors in a research note. More concerning is if demand for relacorilant, which is modeled to be a larger product, would be met if approved by December 30 PDUFA, the firm adds. Published first on TheFly – the ultimate
CORT's Q1 Earnings In Line With Estimates, Revenues Lag, Shares Fall
Corcept's first-quarter 2025 earnings meet estimates while revenues miss the same. The company reiterates its revenue guidance for 2025. Stock down.
Corcept Therapeutics Stock Jumps On Record Prescription Volume: Retail Sentiment Soars
The pharma company saw a surge in retail sentiment following its Q1 update, which reaffirmed its 2025 revenue guidance of $900 million to $950 million.
Corcept Therapeutics (CORT) Meets Q1 Earnings Estimates
Corcept (CORT) delivered earnings and revenue surprises of 0% and 11.66%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: XERS
CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Corcept Therapeutics (CORT): Among Billionaire Jim Simons’ RenTech’s Small-Cap Stock Picks with Huge Upside Potential
We recently published a list of Billionaire Jim Simons’ RenTech’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Corcept Therapeutics Incorporated (NASDAQ:CORT) stands against Billionaire Jim Simons’ RenTech’s other small-cap stock picks with huge upside potential. Jim Simons was (and still is even […]
Why Arista Networks Inc. (ANET) Soared Last Week
We recently published a list of These 10 Firms Soared Last Week, Here’s Why. In this article, we are going to take a look at where Arista Networks Inc. (NYSE:ANET) stands against other firms that soared last week. The past trading week saw a more calm, generally optimistic, market environment amid the temporary pause in tit-for-tat […]
Why QUALCOMM, Inc. (QCOM) is Among the Best Augmented Reality Stocks to Buy According to Hedge Funds
We recently published a list of 11 Best Augmented Reality Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where QUALCOMM, Inc. (NASDAQ:QCOM) stands against other best augmented reality stocks to buy according to hedge funds. According to a report by Mordor Intelligence, the global AR […]
Is Coupang Inc. (NYSE:CPNG) the Best Growth Stock to Buy for the Next 3 Years?
We recently published a list of the 15 Best Growth Stocks to Buy for the Next 3 Years. In this article, we are going to take a look at where Coupang Inc. (NYSE:CPNG) stands against other growth stocks to buy for the next 3 years. On April 29, Dan Ives of Wedbush Securities joined ‘Power […]